Rivaroxaban added to Cat A & M from September

DHSC has announced changes to the reimbursement of rivaroxaban from September:

Moving to Category A:

Rivaroxaban 2.5mg tablets
Rivaroxaban 10mg tablets

Moving to Category M:

Rivaroxaban 15mg tablets
Rivaroxaban 20mg tablets

These additions are being done outside of the usual quarterly timetable. Reimbursement prices will be calculated using information from suppliers obtained under the Health Service Products (Provision and Disclosure of Information) Regulations 2018.

DM Zone news England Wales

Latest news

DDA raises rural GP issues in Westminster event

DDA Board Member Dr Ian Hume raised the rural challenges facing dispensing GPs in a Rebuild General Practice campaign roundtable with Liberal Democrat MPs.The discussion focused on the challenges facing GP practices across the country, from rising de

MSN: lansoprazole 15mg and 30mg orodispersible tablets

DHSC has published a Tier 2 Medicine Supply Notification (MSN) for lansoprazole 15mg and 30mg orodispersible tablets: limited supply until early January 2027. Up-to-date information abour medicine supply issues can be found in the DHSC and NHSE

England & Wales: August price redetermination

The Department of Health and Social Care has confirmed that the reimbursement price for the following products in the table have been redetermined. This is to reflect an increase in the NHS list price. Generic name Brand name Pack size Ne

Rivaroxaban added to Cat A & M from September

Latest news

DDA raises rural GP issues in Westminster event

MSN: lansoprazole 15mg and 30mg orodispersible tablets

England & Wales: August price redetermination

View all news

DDA Suppliers Directory

MediP

Dispensing Doctor Experts

Follow us

Dispensing Doctors' Association

DDA Best Practice Group

Dispensing Doctors' Association